[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Re: Boice, Rad Research, 1/96



> Subject: Boice, Rad Research, 1/96 
> Now that this Jan 96 issue will have been received by those whose orgs 
> can afford it :-) can anyone report on the dose range in this 
> population?  and years of follow-up?  
>  
> >RADIATION RESEARCH 
> >Volume 145, Number 1, January 1996 
> >Table of Contents 
> >Per Hall, Anders Mattsson and John D. Boice, Jr. 
> >Thyroid Cancer after Diagnostic Administration of Iodine-131 (p. 86) 

patients:  34104
age at administration with mean and range:    43(1-75) years
followup with mean and range:    24 (5-39) years
thyroid dose with mean and range:    1.1 (0.0-40.5) Gy
 
observed/expected thyroid cancers:    67/49.1
standardized incidence ratio with 95% CI:    1.35 (1.05-1.71)

Excess incidence confined to patients referred because of suspected thyroid 
tumors, and not related to radiation dose, time since exposure or age at 
exposure.  Note that tumors developing within 5 years of exposure were 
excluded from analysis.

"the slight excess of thyroid cancer thus appeared to be due to the underlying 
thyroid condition and not the radiation exposure"

---soap box on----
If you don't like the cost of the journal, join the Radiation Research 
Society, and then you can get it real cheap.  Full Membership costs $65/yr, 
Assoc $35/yr, and with either you can get the journal for $68/yr (US, Canada, 
Mex?) or $98/yr (elsewhere).
---soap box off----


John Moulder (jmoulder@its.mcw.edu)
Associate Editor
Radiation Research